Total words: 2207 | 2-word phrases: 573 | 3-word phrases: 660 | 4-word phrases: 687
PAGE INFO
Title | Try to keep the title under 60 characters (0 characters) |
Description | Try to keep the meta description between 50 - 160 characters (0 characters) |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | No H1 tag on the page (0 characters) |
ONE WORD PHRASES 287 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | to | | | | | | | 32 | 11.15% |
2 | oxervate | | | | | | | 29 | 10.10% |
3 | the | | | | | | | 20 | 6.97% |
4 | your | | | | | | | 18 | 6.27% |
5 | you | | | | | | | 17 | 5.92% |
6 | use | | | | | | | 17 | 5.92% |
7 | eye | | | | | | | 16 | 5.57% |
8 | of | | | | | | | 14 | 4.88% |
9 | or | | | | | | | 14 | 4.88% |
10 | if | | | | | | | 12 | 4.18% |
TWO WORD PHRASES 573 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | using oxervate? | | | | | | | 8 | 1.40% |
2 | using oxervate | | | | | | | 8 | 1.40% |
3 | how to | | | | | | | 7 | 1.22% |
4 | your doctor | | | | | | | 6 | 1.05% |
5 | to use | | | | | | | 6 | 1.05% |
6 | if you | | | | | | | 6 | 1.05% |
7 | eye drop | | | | | | | 6 | 1.05% |
8 | to your | | | | | | | 5 | 0.87% |
9 | use oxervate | | | | | | | 5 | 0.87% |
10 | use oxervate? | | | | | | | 5 | 0.87% |
11 | side effect | | | | | | | 5 | 0.87% |
12 | of the | | | | | | | 4 | 0.70% |
13 | about nk | | | | | | | 4 | 0.70% |
14 | about oxervate | | | | | | | 4 | 0.70% |
15 | side effects | | | | | | | 4 | 0.70% |
16 | talk to | | | | | | | 4 | 0.70% |
17 | an eye | | | | | | | 4 | 0.70% |
18 | neurotrophic keratitis? | | | | | | | 4 | 0.70% |
19 | use an | | | | | | | 4 | 0.70% |
20 | neurotrophic keratitis | | | | | | | 4 | 0.70% |
THREE WORD PHRASES 660 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | how to use | | | | | | | 6 | 0.91% |
2 | talk to your | | | | | | | 3 | 0.45% |
3 | side effects of | | | | | | | 3 | 0.45% |
4 | connect with us | | | | | | | 3 | 0.45% |
5 | the possible side | | | | | | | 2 | 0.30% |
6 | to use oxervate | | | | | | | 2 | 0.30% |
7 | at least 15 | | | | | | | 2 | 0.30% |
8 | wait at least | | | | | | | 2 | 0.30% |
9 | gettingstoring oxervate patient | | | | | | | 2 | 0.30% |
10 | oxervate patient resources | | | | | | | 2 | 0.30% |
11 | patient resources faq | | | | | | | 2 | 0.30% |
12 | affected eye or | | | | | | | 2 | 0.30% |
13 | to your doctor | | | | | | | 2 | 0.30% |
14 | eye or both | | | | | | | 2 | 0.30% |
15 | oxervate talk to | | | | | | | 2 | 0.30% |
16 | nk about oxervate | | | | | | | 2 | 0.30% |
17 | terms of use | | | | | | | 2 | 0.30% |
18 | while using oxervate | | | | | | | 2 | 0.30% |
19 | or both eyes | | | | | | | 2 | 0.30% |
20 | of the eye | | | | | | | 2 | 0.30% |
21 | possible side effects | | | | | | | 2 | 0.30% |
22 | dompé us inc | | | | | | | 2 | 0.30% |
23 | tell your doctor | | | | | | | 2 | 0.30% |
24 | your doctor about | | | | | | | 2 | 0.30% |
25 | you have an | | | | | | | 2 | 0.30% |
26 | if you have | | | | | | | 2 | 0.30% |
27 | 15 minutes before | | | | | | | 2 | 0.30% |
28 | least 15 minutes | | | | | | | 2 | 0.30% |
29 | about nk about | | | | | | | 2 | 0.30% |
30 | known if oxervate | | | | | | | 2 | 0.30% |
FOUR WORD PHRASES 687 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | at least 15 minutes | | | | | | | 2 | 0.29% |
2 | about nk about oxervate | | | | | | | 2 | 0.29% |
3 | least 15 minutes before | | | | | | | 2 | 0.29% |
4 | oxervate patient resources faq | | | | | | | 2 | 0.29% |
5 | gettingstoring oxervate patient resources | | | | | | | 2 | 0.29% |
6 | possible side effects of | | | | | | | 2 | 0.29% |
7 | the possible side effects | | | | | | | 2 | 0.29% |
8 | affected eye or both | | | | | | | 2 | 0.29% |
9 | how to use oxervate | | | | | | | 2 | 0.29% |
10 | eye or both eyes | | | | | | | 2 | 0.29% |
11 | if you have an | | | | | | | 2 | 0.29% |
12 | wait at least 15 | | | | | | | 2 | 0.29% |
13 | oxervate talk to your | | | | | | | 2 | 0.29% |
14 | information prescribing information patient | | | | | | | 2 | 0.29% |
15 | to avoid one eye | | | | | | | 1 | 0.15% |
16 | help to avoid one | | | | | | | 1 | 0.15% |
17 | oxervate first and then | | | | | | | 1 | 0.15% |
18 | use oxervate first and | | | | | | | 1 | 0.15% |
19 | thick use oxervate first | | | | | | | 1 | 0.15% |
20 | eye drop that is | | | | | | | 1 | 0.15% |
21 | minutes before or after | | | | | | | 1 | 0.15% |
22 | using oxervate this will | | | | | | | 1 | 0.15% |
23 | oxervate this will help | | | | | | | 1 | 0.15% |
24 | this will help to | | | | | | | 1 | 0.15% |
25 | will help to avoid | | | | | | | 1 | 0.15% |
26 | an eye drop that | | | | | | | 1 | 0.15% |
27 | or an eye drop | | | | | | | 1 | 0.15% |
28 | gel or an eye | | | | | | | 1 | 0.15% |
29 | avoid one eye drop | | | | | | | 1 | 0.15% |
30 | or gel or an | | | | | | | 1 | 0.15% |
31 | ointment or gel or | | | | | | | 1 | 0.15% |
32 | eye ointment or gel | | | | | | | 1 | 0.15% |
33 | an eye ointment or | | | | | | | 1 | 0.15% |
34 | and then wait at | | | | | | | 1 | 0.15% |
35 | use an eye ointment | | | | | | | 1 | 0.15% |
36 | also use an eye | | | | | | | 1 | 0.15% |
37 | you also use an | | | | | | | 1 | 0.15% |
38 | if you also use | | | | | | | 1 | 0.15% |
39 | drop if you also | | | | | | | 1 | 0.15% |
40 | eye drop if you | | | | | | | 1 | 0.15% |
EXTERNAL LINKS